Skip to content
healthcare.dev
Get a free key

Irinotecan Hydrochloride

NDC 67184-0513, Irinotecan Hydrochloride, injection, solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0513
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203380
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0513 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
67184-0513-1671840513011 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/afcdde49-ec0c-4c56-a1af-2917185b1a08

Use it

Look up 67184-0513 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0513 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.